Clinical Trial Update: Enbrel-Sulfasalazin-Early-Axial Spondyloarthritis (AS) [Phase 2]

View source ↗

Summary

This is a Phase 2 trial evaluating Enbrel with sulfasalazine for moderate to severe active axial spondyloarthritis; the current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Axial Spondyloarthritis

Drugs mentioned

• ENBREL (etanercept)
• Sulfasalazine (Sulfasalazine)

Snippet

Sponsor: Charite University, Berlin, Germany | Conditions: Moderate to Severe Active Axial Spondyloarthritis | Phase 2 | Status: UNKNOWN